Infectious Disease, Immunity & Inflammation

Impact

We have made substantive, internationally-recognised research contributions to the evidence base that has led to revolutions in the treatment of HIV and Hepatitis C (HCV), the prevention of morbidities of chronic infections (e.g. hepatitis B (HBV), human papillomavirus (HPV), H. pylori., the diagnosis of primary immunodeficiencies, the diagnosis and treatment of antiphospholipid antibody syndrome (APS), and the treatment and prevention of childhood allergies.

We have played a key role in providing the evidence base for the adoption of international best practice, with an active role in determining national and international guidelines developed the World Health Organization and other major agencies.